Whereas the presence of KRAS mutations supports the diagnosis of a mucinous over a non-mucinous cyst, GNAS mutations favor the diagnosis of IPMN over MCN [25,29,65,66,76,79]. Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.